Differential regulation of putative M1/M2 muscarinic receptors: implications for different receptor-effector coupling mechanisms.
D008455:(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001570:Benzodiazepinones / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D005033:Ethylmaleimide / Q000494:pharmacology; D006150:Guanine Nucleotides / Q000494:pharmacology; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D066298:In Vitro Techniques; D008968:Molecular Conformation; D009206:Myocardium / Q000378:metabolism; D010862:Pilocarpine / Q000494:pharmacology; D010890:Pirenzepine; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D051381:Rats; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*
D001570:Benzodiazepinones; D006150:Guanine Nucleotides; D011976:Receptors, Muscarinic; D010862:Pilocarpine; D006165:Guanylyl Imidodiphosphate; D010890:Pirenzepine; D008455:(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; D011813:Quinuclidinyl Benzilate; D000262:Adenylyl Cyclases; D005033:Ethylmaleimide